Sharing clinical laboratory experience at SMFM 2020
We will present results from clinical laboratory experience that indicate noninvasive prenatal testing (NIPT) performs well for predicting aneuploidies in twin pregnancies.
SAN DIEGO – February 5, 2020 – Progenity, developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, will present results from clinical laboratory experience that indicate noninvasive prenatal testing (NIPT) performs well for predicting aneuploidies in twin pregnancies. The data will be shared at the Society for Maternal Fetal Medicine’s 40th Annual Meeting, The Pregnancy MeetingTM, which takes place in Grapevine, Texas, February 3 through 8.
Details of the presentation are as follows:
Title – Noninvasive prenatal screening for fetal aneuploidy in twin pregnancies: A clinical laboratory experience
Presenting author – Craig Adamski, MS, CGC
Poster number – 1057
Date and time – Saturday, February 8, 11:30 AM to 1:00 PM CST
The abstract is available in the American Journal of Obstetrics & Gynecology and the full poster will be made available here after the conference.
Clinical Publications
Learn more about our clinical publications.
